SORRENTO THERAPEUTICS, INC. Increase (Decrease) in Inventories
SORRENTO THERAPEUTICS, INC. reported Increase (Decrease) in Inventories of $1.83 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2023-08-14
- SORRENTO THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2023-06-30 was $498.00K, a 90.77% decline year-over-year.
- SORRENTO THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2023-03-31 was $1.33M, a 77.71% decline year-over-year.
- SORRENTO THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2022-12-31 was $5.01M, a 490.58% increase year-over-year.
- SORRENTO THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2022-09-30 was -$6.88M, a 350.78% decline year-over-year.
- SORRENTO THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2022 was $9.51M, a 51.53% increase from fiscal 2021.
- SORRENTO THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2021 was $6.28M.
- SORRENTO THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2020 was -$1.53M.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2023-06-30 | $498.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.83M 10-Q · filed 2023-08-14 | $6.84M derived: sum of 3 quarters · filed 2023-08-14 | -$34.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | $1.33M 10-Q · filed 2023-05-15 | $6.35M derived: sum of 2 quarters · filed 2023-05-15 | -$532.00K derived: sum of 3 quarters · filed 2023-05-15 | $4.86M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-12-31 | $5.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$1.86M derived: sum of 2 quarters · filed 2023-03-16 | $3.53M derived: sum of 3 quarters · filed 2023-08-14 | $9.51M 10-K · filed 2023-03-16 |
| 2022-09-30 | -$6.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$1.48M derived: sum of 2 quarters · filed 2023-08-14 | $4.50M 10-Q · filed 2022-11-08 | $5.34M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-06-30 | $5.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $11.38M 10-Q · filed 2023-08-14 | $12.22M derived: sum of 3 quarters · filed 2023-08-14 | $14.97M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $5.98M 10-Q · filed 2023-05-15 | $6.83M derived: sum of 2 quarters · filed 2023-05-15 | $9.57M derived: sum of 3 quarters · filed 2023-05-15 | $12.31M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $849.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $3.59M derived: sum of 2 quarters · filed 2023-03-16 | $6.33M derived: sum of 3 quarters · filed 2023-03-16 | $6.28M 10-K · filed 2023-03-16 |
| 2021-09-30 | $2.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $5.48M derived: sum of 2 quarters · filed 2022-11-08 | $5.43M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $2.68M 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | -$51.00K 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | -$1.53M 10-K · filed 2023-03-16 |